Mascarenhas Summarizes Therapeutic Standards and Advances in Myelofibrosis Management

Dr Mascarenhas discusses established standards of care and ongoing research with JAK inhibitors in patients with myelofibrosis; the available frontline treatment options in this disease; and the nuances of myelofibrosis treatment sequencing.